您当前的位置：
首页 >
文章列表页 >
Clinical Comprehensive Evaluation of Tongxiening Granules in Treatment of Diarrhea-predominant Irritable Bowel Syndrome with Liver Qi Invading Spleen Syndrome
更新时间：2024-04-30
|

    • Clinical Comprehensive Evaluation of Tongxiening Granules in Treatment of Diarrhea-predominant Irritable Bowel Syndrome with Liver Qi Invading Spleen Syndrome

      增强出版
    • “一项关于痛泻宁颗粒治疗腹泻型肠易激综合征（IBS-D）肝气犯脾证的论文摘要发布。该摘要系统地梳理了痛泻宁颗粒的现有临床证据，并从“6+1”维度进行了综合价值评估。评估结果显示，痛泻宁颗粒在治疗IBS-D方面表现出良好的安全性、有效性和经济性，同时具有创新性和适宜性，且价格适中，可及性高。此外，该药物源于经典名方，具有突出的中医药特色。综合评估分数为0.83分，表明痛泻宁颗粒治疗IBS-D肝气犯脾证的临床价值证据充足。这一研究为临床决策和药事管理提供了重要参考，未来建议进一步开展网状Meta分析，以提高痛泻宁颗粒的循证证据质量，充分发挥其临床价值优势。”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 11, Pages: 139-149(2024)

    • DOI：10.13422/j.cnki.syfjx.20241492    

      CLC： R242;R2-031;R287;R286;R574

    • Published：05 June 2024，

      Published Online：12 April 2024，

      Received：29 March 2024，

    扫 描 看 全 文

  • LU Zhenkai,XIE Yanming.Clinical Comprehensive Evaluation of Tongxiening Granules in Treatment of Diarrhea-predominant Irritable Bowel Syndrome with Liver Qi Invading Spleen Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(11):139-149. DOI： 10.13422/j.cnki.syfjx.20241492.

  •  
  •  

0

Views

18

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Comprehensive Evaluation of Clinical Evidence and Value of Feilike Mixture in Treatment of Acute Bronchitis with Phlegm-heat Invading Lung
Construction and Interpretation of Clinical Comprehensive Evaluation Index System for Chinese Patent Medicine Based on EVIDEM Framework
Comprehensive Clinical Evaluation of Yiqing Capsules in Treating Heat-toxin Syndrome
Current Situation on Clinical Comprehensive Evaluation of Chinese Patent Medicines in China

Related Author

SHI Bowen
ZHANG Qiang
WANG Zhifei
CUI Xin
DAI Zeqi
JING Chengyang
WU Xue
ZHANG Le

Related Institution

The First Affiliated Hospital of Henan University of Chinese Medicine
Institute of Basic ResearchMedicine，China Academy of Chinese Medical Sciences
The research center of national drug policy & ecosystem，China pharmaceutical university
China Academy of Chinese Medical Sciences
NMPA Key Laboratory for Drug Regulatory Innovation and Evaluation，China Pharmaceutical University
0